nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—ABCB1—Topotecan—cervical cancer	0.0523	0.625	CbGbCtD
Olanzapine—CHRM3—ureter—cervical cancer	0.0507	0.124	CbGeAlD
Olanzapine—H1F0—semen—cervical cancer	0.0364	0.0892	CbGeAlD
Olanzapine—CYP3A4—Topotecan—cervical cancer	0.0313	0.375	CbGbCtD
Olanzapine—CHRM3—exocrine gland—cervical cancer	0.01	0.0245	CbGeAlD
Olanzapine—FMO3—mammalian vulva—cervical cancer	0.00794	0.0194	CbGeAlD
Olanzapine—CHRM5—epithelium—cervical cancer	0.00778	0.019	CbGeAlD
Olanzapine—HTR1E—female gonad—cervical cancer	0.00767	0.0188	CbGeAlD
Olanzapine—H1F0—uterine cervix—cervical cancer	0.00665	0.0163	CbGeAlD
Olanzapine—ADRA1B—renal system—cervical cancer	0.00659	0.0161	CbGeAlD
Olanzapine—DRD5—female reproductive system—cervical cancer	0.00644	0.0158	CbGeAlD
Olanzapine—H1F0—decidua—cervical cancer	0.00634	0.0155	CbGeAlD
Olanzapine—H1F0—renal system—cervical cancer	0.00622	0.0152	CbGeAlD
Olanzapine—FMO3—vagina—cervical cancer	0.00615	0.0151	CbGeAlD
Olanzapine—H1F0—endometrium—cervical cancer	0.00602	0.0147	CbGeAlD
Olanzapine—DRD5—female gonad—cervical cancer	0.00586	0.0144	CbGeAlD
Olanzapine—H1F0—mammalian vulva—cervical cancer	0.00582	0.0143	CbGeAlD
Olanzapine—H1F0—uterus—cervical cancer	0.00554	0.0136	CbGeAlD
Olanzapine—ORM1—endometrium—cervical cancer	0.00513	0.0126	CbGeAlD
Olanzapine—H1F0—female reproductive system—cervical cancer	0.00498	0.0122	CbGeAlD
Olanzapine—HTR2B—uterine cervix—cervical cancer	0.00479	0.0117	CbGeAlD
Olanzapine—HTR2B—decidua—cervical cancer	0.00457	0.0112	CbGeAlD
Olanzapine—H1F0—female gonad—cervical cancer	0.00454	0.0111	CbGeAlD
Olanzapine—H1F0—vagina—cervical cancer	0.00451	0.011	CbGeAlD
Olanzapine—HTR2B—endometrium—cervical cancer	0.00434	0.0106	CbGeAlD
Olanzapine—ORM1—female reproductive system—cervical cancer	0.00425	0.0104	CbGeAlD
Olanzapine—HTR7—epithelium—cervical cancer	0.00414	0.0101	CbGeAlD
Olanzapine—CHRM3—renal system—cervical cancer	0.00403	0.00988	CbGeAlD
Olanzapine—HTR1A—renal system—cervical cancer	0.00402	0.00984	CbGeAlD
Olanzapine—HTR2B—uterus—cervical cancer	0.004	0.00978	CbGeAlD
Olanzapine—ADRA1A—epithelium—cervical cancer	0.00399	0.00978	CbGeAlD
Olanzapine—HTR1B—female reproductive system—cervical cancer	0.00399	0.00977	CbGeAlD
Olanzapine—FMO3—lymph node—cervical cancer	0.00398	0.00974	CbGeAlD
Olanzapine—HTR1D—female reproductive system—cervical cancer	0.00386	0.00945	CbGeAlD
Olanzapine—HTR7—renal system—cervical cancer	0.00384	0.0094	CbGeAlD
Olanzapine—HTR2C—female reproductive system—cervical cancer	0.00382	0.00936	CbGeAlD
Olanzapine—ADRA2C—uterine cervix—cervical cancer	0.00377	0.00924	CbGeAlD
Olanzapine—ADRA1A—renal system—cervical cancer	0.0037	0.00907	CbGeAlD
Olanzapine—CHRM1—female reproductive system—cervical cancer	0.00361	0.00884	CbGeAlD
Olanzapine—ADRA2C—decidua—cervical cancer	0.00359	0.0088	CbGeAlD
Olanzapine—HTR2B—female reproductive system—cervical cancer	0.00359	0.00879	CbGeAlD
Olanzapine—HRH2—lymph node—cervical cancer	0.00354	0.00867	CbGeAlD
Olanzapine—ADRA2C—renal system—cervical cancer	0.00353	0.00864	CbGeAlD
Olanzapine—ADRA2C—endometrium—cervical cancer	0.00341	0.00836	CbGeAlD
Olanzapine—ADRA2C—mammalian vulva—cervical cancer	0.0033	0.00808	CbGeAlD
Olanzapine—HTR2B—vagina—cervical cancer	0.00325	0.00795	CbGeAlD
Olanzapine—CHRM3—female reproductive system—cervical cancer	0.00323	0.00791	CbGeAlD
Olanzapine—ADRA2C—uterus—cervical cancer	0.00314	0.0077	CbGeAlD
Olanzapine—HRH1—epithelium—cervical cancer	0.00309	0.00757	CbGeAlD
Olanzapine—HTR7—female reproductive system—cervical cancer	0.00308	0.00753	CbGeAlD
Olanzapine—HRH1—uterine cervix—cervical cancer	0.00306	0.00751	CbGeAlD
Olanzapine—CYP1A2—renal system—cervical cancer	0.00306	0.0075	CbGeAlD
Olanzapine—ADRA2A—uterine cervix—cervical cancer	0.00301	0.00737	CbGeAlD
Olanzapine—CHRM3—female gonad—cervical cancer	0.00294	0.0072	CbGeAlD
Olanzapine—HRH1—decidua—cervical cancer	0.00292	0.00715	CbGeAlD
Olanzapine—H1F0—lymph node—cervical cancer	0.00292	0.00714	CbGeAlD
Olanzapine—ADRA2A—decidua—cervical cancer	0.00287	0.00702	CbGeAlD
Olanzapine—HRH1—endometrium—cervical cancer	0.00277	0.00679	CbGeAlD
Olanzapine—ADRA2A—endometrium—cervical cancer	0.00272	0.00667	CbGeAlD
Olanzapine—CYP2C19—vagina—cervical cancer	0.00272	0.00665	CbGeAlD
Olanzapine—HRH1—mammalian vulva—cervical cancer	0.00268	0.00657	CbGeAlD
Olanzapine—ADRA2A—mammalian vulva—cervical cancer	0.00263	0.00645	CbGeAlD
Olanzapine—HTR2A—epithelium—cervical cancer	0.00258	0.00632	CbGeAlD
Olanzapine—ADRA2C—female gonad—cervical cancer	0.00257	0.0063	CbGeAlD
Olanzapine—ADRA2C—vagina—cervical cancer	0.00256	0.00626	CbGeAlD
Olanzapine—ADRA2A—uterus—cervical cancer	0.00251	0.00614	CbGeAlD
Olanzapine—ORM1—lymph node—cervical cancer	0.00249	0.00609	CbGeAlD
Olanzapine—HTR2A—renal system—cervical cancer	0.00239	0.00586	CbGeAlD
Olanzapine—CYP2C9—female reproductive system—cervical cancer	0.00233	0.0057	CbGeAlD
Olanzapine—HRH1—female reproductive system—cervical cancer	0.0023	0.00562	CbGeAlD
Olanzapine—ADRA2A—female reproductive system—cervical cancer	0.00226	0.00552	CbGeAlD
Olanzapine—CYP3A4—renal system—cervical cancer	0.00222	0.00543	CbGeAlD
Olanzapine—ALB—lymph node—cervical cancer	0.00218	0.00534	CbGeAlD
Olanzapine—CYP2D6—renal system—cervical cancer	0.00218	0.00534	CbGeAlD
Olanzapine—HTR2B—lymph node—cervical cancer	0.0021	0.00514	CbGeAlD
Olanzapine—HRH1—female gonad—cervical cancer	0.00209	0.00512	CbGeAlD
Olanzapine—HRH1—vagina—cervical cancer	0.00208	0.00509	CbGeAlD
Olanzapine—ADRA2A—female gonad—cervical cancer	0.00205	0.00503	CbGeAlD
Olanzapine—ADRA2A—vagina—cervical cancer	0.00204	0.005	CbGeAlD
Olanzapine—HTR2A—female reproductive system—cervical cancer	0.00192	0.0047	CbGeAlD
Olanzapine—CYP3A4—female reproductive system—cervical cancer	0.00178	0.00435	CbGeAlD
Olanzapine—CYP2D6—female reproductive system—cervical cancer	0.00175	0.00428	CbGeAlD
Olanzapine—HTR2A—vagina—cervical cancer	0.00173	0.00425	CbGeAlD
Olanzapine—ABCB1—epithelium—cervical cancer	0.00169	0.00414	CbGeAlD
Olanzapine—ABCB1—uterine cervix—cervical cancer	0.00168	0.00411	CbGeAlD
Olanzapine—ADRA2C—lymph node—cervical cancer	0.00165	0.00405	CbGeAlD
Olanzapine—ABCB1—decidua—cervical cancer	0.0016	0.00391	CbGeAlD
Olanzapine—CYP2D6—female gonad—cervical cancer	0.00159	0.00389	CbGeAlD
Olanzapine—ABCB1—renal system—cervical cancer	0.00157	0.00384	CbGeAlD
Olanzapine—ABCB1—endometrium—cervical cancer	0.00152	0.00372	CbGeAlD
Olanzapine—ABCB1—mammalian vulva—cervical cancer	0.00147	0.00359	CbGeAlD
Olanzapine—ABCB1—uterus—cervical cancer	0.0014	0.00342	CbGeAlD
Olanzapine—HRH1—lymph node—cervical cancer	0.00134	0.00329	CbGeAlD
Olanzapine—ADRA2A—lymph node—cervical cancer	0.00132	0.00323	CbGeAlD
Olanzapine—ABCB1—female reproductive system—cervical cancer	0.00126	0.00308	CbGeAlD
Olanzapine—ABCB1—female gonad—cervical cancer	0.00114	0.0028	CbGeAlD
Olanzapine—ABCB1—vagina—cervical cancer	0.00114	0.00278	CbGeAlD
Olanzapine—ABCB1—lymph node—cervical cancer	0.000735	0.0018	CbGeAlD
Olanzapine—HTR1B—Signaling Pathways—NOTCH1—cervical cancer	7.3e-05	0.000144	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—MTOR—cervical cancer	7.29e-05	0.000144	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—FGFR3—cervical cancer	7.23e-05	0.000142	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—NOTCH1—cervical cancer	7.18e-05	0.000141	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—HES1—cervical cancer	7.13e-05	0.00014	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—NOTCH1—cervical cancer	7.09e-05	0.000139	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	7.06e-05	0.000139	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—HES1—cervical cancer	7.01e-05	0.000138	CbGpPWpGaD
Olanzapine—ADRA2C—Hemostasis—TP53—cervical cancer	7.01e-05	0.000138	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—FGFR3—cervical cancer	6.89e-05	0.000136	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—NOTCH1—cervical cancer	6.86e-05	0.000135	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—FGFR3—cervical cancer	6.8e-05	0.000134	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—NOTCH1—cervical cancer	6.79e-05	0.000134	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—CASP3—cervical cancer	6.75e-05	0.000133	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—CASP3—cervical cancer	6.71e-05	0.000132	CbGpPWpGaD
Olanzapine—HTR6—Signaling by GPCR—EGFR—cervical cancer	6.69e-05	0.000132	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TERT—cervical cancer	6.69e-05	0.000132	CbGpPWpGaD
Olanzapine—HTR7—Signaling by GPCR—EGFR—cervical cancer	6.69e-05	0.000132	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—EGFR—cervical cancer	6.65e-05	0.000131	CbGpPWpGaD
Olanzapine—HTR1D—Signaling by GPCR—EGFR—cervical cancer	6.64e-05	0.000131	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—MTHFR—cervical cancer	6.63e-05	0.00013	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—CTNNB1—cervical cancer	6.51e-05	0.000128	CbGpPWpGaD
Olanzapine—HTR1B—Signaling by GPCR—EGFR—cervical cancer	6.5e-05	0.000128	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—HES1—cervical cancer	6.47e-05	0.000127	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—NOTCH1—cervical cancer	6.47e-05	0.000127	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—CTNNB1—cervical cancer	6.47e-05	0.000127	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TERT—cervical cancer	6.45e-05	0.000127	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TERT—cervical cancer	6.42e-05	0.000126	CbGpPWpGaD
Olanzapine—DRD4—Signaling by GPCR—EGFR—cervical cancer	6.4e-05	0.000126	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CA9—cervical cancer	6.39e-05	0.000126	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—NOTCH1—cervical cancer	6.38e-05	0.000126	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—STAT3—cervical cancer	6.37e-05	0.000125	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—HES1—cervical cancer	6.36e-05	0.000125	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—HES1—cervical cancer	6.35e-05	0.000125	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—HES1—cervical cancer	6.33e-05	0.000125	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—EGFR—cervical cancer	6.31e-05	0.000124	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—HES1—cervical cancer	6.31e-05	0.000124	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—HES1—cervical cancer	6.25e-05	0.000123	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TERT—cervical cancer	6.25e-05	0.000123	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—HES1—cervical cancer	6.23e-05	0.000123	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TERT—cervical cancer	6.15e-05	0.000121	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	6.14e-05	0.000121	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—EGFR—cervical cancer	6.11e-05	0.00012	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—MTHFR—cervical cancer	6.08e-05	0.00012	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—EGFR—cervical cancer	6.05e-05	0.000119	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—FGFR3—cervical cancer	5.92e-05	0.000117	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—FGFR3—cervical cancer	5.89e-05	0.000116	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—HES1—cervical cancer	5.79e-05	0.000114	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—EGFR—cervical cancer	5.79e-05	0.000114	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—EGFR—cervical cancer	5.76e-05	0.000113	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	5.76e-05	0.000113	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	5.73e-05	0.000113	CbGpPWpGaD
Olanzapine—ADRA2A—Hemostasis—TP53—cervical cancer	5.7e-05	0.000112	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—EGFR—cervical cancer	5.68e-05	0.000112	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—STAT3—cervical cancer	5.67e-05	0.000112	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TERT—cervical cancer	5.67e-05	0.000112	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	5.64e-05	0.000111	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—STAT3—cervical cancer	5.64e-05	0.000111	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—MTOR—cervical cancer	5.63e-05	0.000111	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—MTOR—cervical cancer	5.62e-05	0.000111	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—MTOR—cervical cancer	5.59e-05	0.00011	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—TP53—cervical cancer	5.58e-05	0.00011	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TERT—cervical cancer	5.58e-05	0.00011	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TERT—cervical cancer	5.56e-05	0.00011	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	5.56e-05	0.000109	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TERT—cervical cancer	5.55e-05	0.000109	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	5.53e-05	0.000109	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TERT—cervical cancer	5.53e-05	0.000109	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TERT—cervical cancer	5.47e-05	0.000108	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—MTOR—cervical cancer	5.47e-05	0.000108	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TERT—cervical cancer	5.46e-05	0.000107	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—MTOR—cervical cancer	5.38e-05	0.000106	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	5.38e-05	0.000106	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—MTOR—cervical cancer	5.31e-05	0.000105	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	5.3e-05	0.000104	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—FGFR3—cervical cancer	5.2e-05	0.000102	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—CASP3—cervical cancer	5.18e-05	0.000102	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—CASP3—cervical cancer	5.17e-05	0.000102	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—EGFR—cervical cancer	5.16e-05	0.000101	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—MTOR—cervical cancer	5.14e-05	0.000101	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—CASP3—cervical cancer	5.14e-05	0.000101	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	5.13e-05	0.000101	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—EGFR—cervical cancer	5.12e-05	0.000101	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—FGFR3—cervical cancer	5.12e-05	0.000101	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—FGFR3—cervical cancer	5.11e-05	0.0001	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—FGFR3—cervical cancer	5.09e-05	0.0001	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MTOR—cervical cancer	5.09e-05	0.0001	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—FGFR3—cervical cancer	5.07e-05	9.99e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TERT—cervical cancer	5.07e-05	9.98e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—CASP3—cervical cancer	5.03e-05	9.9e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—FGFR3—cervical cancer	5.02e-05	9.89e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	5.01e-05	9.86e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—CTNNB1—cervical cancer	4.99e-05	9.82e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—CTNNB1—cervical cancer	4.99e-05	9.81e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—EGFR—cervical cancer	4.95e-05	9.75e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—CTNNB1—cervical cancer	4.95e-05	9.75e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—CASP3—cervical cancer	4.95e-05	9.74e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—EGFR—cervical cancer	4.93e-05	9.7e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—CASP3—cervical cancer	4.88e-05	9.61e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—NOTCH1—cervical cancer	4.88e-05	9.61e-05	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—TP53—cervical cancer	4.86e-05	9.56e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—CTNNB1—cervical cancer	4.85e-05	9.54e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MTOR—cervical cancer	4.85e-05	9.54e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	4.8e-05	9.46e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—MTHFR—cervical cancer	4.8e-05	9.45e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	4.79e-05	9.44e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—NOTCH1—cervical cancer	4.79e-05	9.43e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MTOR—cervical cancer	4.78e-05	9.41e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—NOTCH1—cervical cancer	4.78e-05	9.4e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—CTNNB1—cervical cancer	4.77e-05	9.39e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—NOTCH1—cervical cancer	4.76e-05	9.37e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—CASP3—cervical cancer	4.73e-05	9.3e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	4.72e-05	9.29e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—NOTCH1—cervical cancer	4.72e-05	9.28e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—CTNNB1—cervical cancer	4.71e-05	9.27e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	4.7e-05	9.26e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—CASP3—cervical cancer	4.68e-05	9.21e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	4.66e-05	9.16e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—CTNNB1—cervical cancer	4.56e-05	8.97e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—CTNNB1—cervical cancer	4.51e-05	8.87e-05	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—TP53—cervical cancer	4.5e-05	8.85e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—CASP3—cervical cancer	4.46e-05	8.77e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—CASP3—cervical cancer	4.4e-05	8.66e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	4.37e-05	8.6e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—STAT3—cervical cancer	4.35e-05	8.56e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—EGFR—cervical cancer	4.35e-05	8.56e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—STAT3—cervical cancer	4.35e-05	8.55e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—TP53—cervical cancer	4.33e-05	8.52e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—STAT3—cervical cancer	4.32e-05	8.5e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MTOR—cervical cancer	4.32e-05	8.5e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—MTHFR—cervical cancer	4.31e-05	8.48e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—TP53—cervical cancer	4.3e-05	8.46e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—CTNNB1—cervical cancer	4.3e-05	8.46e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—EGFR—cervical cancer	4.28e-05	8.42e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—EGFR—cervical cancer	4.27e-05	8.41e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—EGFR—cervical cancer	4.26e-05	8.38e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—EGFR—cervical cancer	4.24e-05	8.35e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—CTNNB1—cervical cancer	4.24e-05	8.34e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—STAT3—cervical cancer	4.23e-05	8.32e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—MTHFR—cervical cancer	4.21e-05	8.28e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—EGFR—cervical cancer	4.2e-05	8.27e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	4.19e-05	8.25e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MTOR—cervical cancer	4.17e-05	8.2e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—STAT3—cervical cancer	4.16e-05	8.19e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MTOR—cervical cancer	4.15e-05	8.16e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—STAT3—cervical cancer	4.1e-05	8.08e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MTOR—cervical cancer	4.03e-05	7.94e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—STAT3—cervical cancer	3.97e-05	7.82e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CASP3—cervical cancer	3.97e-05	7.81e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MTOR—cervical cancer	3.97e-05	7.81e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—MTHFR—cervical cancer	3.96e-05	7.8e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—EGFR—cervical cancer	3.95e-05	7.78e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—EGFR—cervical cancer	3.95e-05	7.77e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—MTHFR—cervical cancer	3.93e-05	7.73e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—STAT3—cervical cancer	3.93e-05	7.73e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—EGFR—cervical cancer	3.92e-05	7.72e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	3.89e-05	7.66e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—EGFR—cervical cancer	3.84e-05	7.56e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CASP3—cervical cancer	3.83e-05	7.54e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	3.83e-05	7.53e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CASP3—cervical cancer	3.81e-05	7.5e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—EGFR—cervical cancer	3.78e-05	7.44e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—STAT3—cervical cancer	3.74e-05	7.37e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—EGFR—cervical cancer	3.73e-05	7.34e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CASP3—cervical cancer	3.71e-05	7.3e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—STAT3—cervical cancer	3.69e-05	7.27e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	3.69e-05	7.27e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	3.68e-05	7.23e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MTOR—cervical cancer	3.66e-05	7.2e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CASP3—cervical cancer	3.65e-05	7.18e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—EGFR—cervical cancer	3.61e-05	7.1e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MTOR—cervical cancer	3.6e-05	7.08e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MTOR—cervical cancer	3.59e-05	7.07e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MTOR—cervical cancer	3.58e-05	7.05e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	3.57e-05	7.04e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—EGFR—cervical cancer	3.57e-05	7.03e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MTOR—cervical cancer	3.57e-05	7.02e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MTOR—cervical cancer	3.53e-05	6.96e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MTOR—cervical cancer	3.52e-05	6.94e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	3.52e-05	6.92e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—EGFR—cervical cancer	3.4e-05	6.7e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CASP3—cervical cancer	3.36e-05	6.62e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—MTHFR—cervical cancer	3.36e-05	6.61e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—EGFR—cervical cancer	3.36e-05	6.61e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—STAT3—cervical cancer	3.34e-05	6.57e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—TP53—cervical cancer	3.32e-05	6.53e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—TP53—cervical cancer	3.32e-05	6.53e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CASP3—cervical cancer	3.31e-05	6.52e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CASP3—cervical cancer	3.3e-05	6.5e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—TP53—cervical cancer	3.29e-05	6.48e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CASP3—cervical cancer	3.29e-05	6.48e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CASP3—cervical cancer	3.28e-05	6.46e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MTOR—cervical cancer	3.27e-05	6.45e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CASP3—cervical cancer	3.25e-05	6.4e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CTNNB1—cervical cancer	3.24e-05	6.38e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CASP3—cervical cancer	3.24e-05	6.38e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—TP53—cervical cancer	3.23e-05	6.35e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—STAT3—cervical cancer	3.22e-05	6.34e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—STAT3—cervical cancer	3.2e-05	6.31e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	3.19e-05	6.28e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CTNNB1—cervical cancer	3.18e-05	6.27e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CTNNB1—cervical cancer	3.17e-05	6.25e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—TP53—cervical cancer	3.17e-05	6.25e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CTNNB1—cervical cancer	3.16e-05	6.23e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CTNNB1—cervical cancer	3.13e-05	6.17e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TP53—cervical cancer	3.13e-05	6.16e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	3.12e-05	6.15e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—STAT3—cervical cancer	3.12e-05	6.13e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—STAT3—cervical cancer	3.07e-05	6.04e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—EGFR—cervical cancer	3.03e-05	5.97e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TP53—cervical cancer	3.03e-05	5.96e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CASP3—cervical cancer	3.01e-05	5.93e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TP53—cervical cancer	3e-05	5.9e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EGFR—cervical cancer	2.93e-05	5.76e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EGFR—cervical cancer	2.91e-05	5.73e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	2.9e-05	5.71e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TP53—cervical cancer	2.86e-05	5.62e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EGFR—cervical cancer	2.83e-05	5.57e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—STAT3—cervical cancer	2.83e-05	5.56e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TP53—cervical cancer	2.82e-05	5.55e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EGFR—cervical cancer	2.79e-05	5.49e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—STAT3—cervical cancer	2.78e-05	5.48e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—STAT3—cervical cancer	2.78e-05	5.46e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—STAT3—cervical cancer	2.77e-05	5.45e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—STAT3—cervical cancer	2.76e-05	5.43e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—STAT3—cervical cancer	2.73e-05	5.38e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—STAT3—cervical cancer	2.72e-05	5.36e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—MTHFR—cervical cancer	2.59e-05	5.1e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EGFR—cervical cancer	2.57e-05	5.06e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TP53—cervical cancer	2.55e-05	5.01e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—STAT3—cervical cancer	2.53e-05	4.98e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EGFR—cervical cancer	2.53e-05	4.98e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EGFR—cervical cancer	2.52e-05	4.97e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EGFR—cervical cancer	2.51e-05	4.95e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EGFR—cervical cancer	2.51e-05	4.93e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EGFR—cervical cancer	2.48e-05	4.89e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EGFR—cervical cancer	2.48e-05	4.87e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TP53—cervical cancer	2.46e-05	4.84e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TP53—cervical cancer	2.44e-05	4.81e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TP53—cervical cancer	2.38e-05	4.68e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TP53—cervical cancer	2.34e-05	4.61e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EGFR—cervical cancer	2.3e-05	4.53e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TP53—cervical cancer	2.16e-05	4.25e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TP53—cervical cancer	2.12e-05	4.18e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TP53—cervical cancer	2.12e-05	4.17e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TP53—cervical cancer	2.11e-05	4.16e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TP53—cervical cancer	2.1e-05	4.14e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TP53—cervical cancer	2.08e-05	4.1e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TP53—cervical cancer	2.08e-05	4.09e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TP53—cervical cancer	1.93e-05	3.8e-05	CbGpPWpGaD
